StreetInsider.com News Articles

Concentra Group Holdings Parent Inc (CON) PT Raised to $43 at JPMorgan

Thu, 10 Sep 2026 08:36:59 -0400

JPMorgan analyst Benjamin Rossi raised the price target on Concentra Group Holdings Parent Inc (NYSE: CON) to $43.00 (from $34.00) while maintaining a Overweight rating.

Form 8-K Concentra Group Holdings For: Sep 04

Tue, 08 Sep 2026 16:43:00 -0400

si-local-file:///var/storage/secattach/20260908/27037272.html

Concentra names Tanner Newton as next CFO, effective Nov. 2026

Tue, 08 Sep 2026 09:00:22 -0400

Concentra (NYSE: CON) announced that Tanner Newton, currently senior vice president of strategy and finance, will become executive vice president and chief financial officer effective Nov. 1, 2026.

Newton's appointment is part of a multiyear leadership succession plan previously announced by Concentra and unanimously approved by its board of directors. He will continue to report to Matt DiCanio, who currently serves as president and CFO and will transition to president and chief executive officer on the same date.

In his new role, Newton will oversee accounting, financial reporting, financial planning and analysis, treasury, tax, capital markets, corporate development, and investor relations.

Newton joined

Concentra Appoints Tanner Newton Chief Financial Officer

Tue, 08 Sep 2026 09:00:00 -0400

Experienced Concentra leader brings deep knowledge of the company’s strategy, financial operations and investor community

DALLAS--(BUSINESS WIRE)-- Concentra® (NYSE: CON), the nation’s leader in occupational medicine and workforce health services, today announced that Tanner Newton, senior vice president of strategy and finance, has been appointed executive vice president and chief financial officer, effective Nov. 1, 2026.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908629564/en/

Tanner Newton

Newton will continue to report to Matt DiCanio, Concentra’s president and chief financial officer,

Concentra Appoints Tanner Newton Chief Financial Officer

Tue, 08 Sep 2026 09:00:00 -0400

Experienced Concentra leader brings deep knowledge of the company’s strategy, financial operations and investor community

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260908629564/en/

Tanner Newton

Newton will continue to report to Matt DiCanio, Concentra’s president and chief financial officer,

Form SCHEDULE 13D/A Concentra Group Holdings Filed by: ORTENZIO ROBERT A

Tue, 01 Sep 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260901/27013261.html

Form 4/A Concentra Group Holdings For: Aug 21 Filed by: ORTENZIO ROBERT A

Tue, 01 Sep 2026 16:10:00 -0400

si-local-file:///var/storage/secattach/20260901/27012899.html

Form 8-K Concentra Group Holdings For: Aug 21

Thu, 27 Aug 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260827/26990792.html

Form 8-K Concentra Group Holdings For: Aug 21

Thu, 27 Aug 2026 16:50:00 -0400

si-local-file:///var/storage/secattach/20260827/26990792.html

Form 4 Concentra Group Holdings For: Aug 21 Filed by: ORTENZIO ROBERT A

Tue, 25 Aug 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260825/26975589.html

Form 4 Concentra Group Holdings For: Aug 21 Filed by: ORTENZIO ROBERT A

Tue, 25 Aug 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260825/26975589.html

Form SCHEDULE 13D/A Concentra Group Holdings Filed by: ORTENZIO ROBERT A

Mon, 24 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260824/26968507.html

Form SCHEDULE 13D/A Concentra Group Holdings Filed by: ORTENZIO ROBERT A

Mon, 24 Aug 2026 16:30:00 -0400

si-local-file:///var/storage/secattach/20260824/26968507.html

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

Dr. Rosenthal returns to Concentra, where she previously held physician leadership roles including area medical director. Most recently, she served as chief medical officer at Zenith Insurance Company for more than 16 years. She also currently serves as the 2026 president of the American College of Occupational and Environmental Medicine.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra names new chief medical officer effective Jan. 2027

Tue, 18 Aug 2026 09:00:51 -0400

Concentra (NYSE: CON) announced that Jill Rosenthal, MD, MPH, will join the company Sept. 1 and assume the role of chief medical officer effective Jan. 1, 2027.

In her new role, Dr. Rosenthal will oversee Concentra's national clinical strategy, physician leadership, quality and patient safety initiatives, evidence-based care programs, and medical innovation.

She

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health